Moderna shares underperformed the broader S&P 500 Index on August 6, 2025. The company is based in Cambridge, Massachusetts.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.12:39
  • Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sat 22:35
• SPX →

  Slovak company

  • Market analysts are examining how AI dominance may lead to job losses and how profit margins are influencing stock prices.12:52
  • SEC filing reported ETF holdings involving SPX on October 19, 2026.Tue 01:45

Related events

• Moderna's stock gains are being driven by FDA approval and the broader growth of AI businesses, as a Nasdaq constituent.Oct 17
• Multiple financial firms acquired, increased, or lessened stakes in Moderna shares, while the company president also sold shares.Oct 14
• Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.Oct 15
• Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.Oct 8
• President Stephen Hoge sold shares of Moderna stock.Oct 16